Number of the records: 1
lenograstim
SYS d000078224 LBL 02009nz--a2200325n--4500 003 CZ-PrNML 005 20260123161336.2 008 0000-n-ancnnbaba----------||-ana-----d 035 $a (DNLM)D000078224 040 $a ABA008 $b cze $f czmesh 072 $a D09. $x 400. $x 430. $x 775. $x 200. $x 750 072 $a D12. $x 644. $x 276. $x 374. $x 410. $x 240. $x 350. $x 750 072 $a D12. $x 776. $x 395. $x 240. $x 200. $x 750 072 $a D12. $x 776. $x 467. $x 374. $x 410. $x 240. $x 350. $x 750 072 $a D23. $x 529. $x 374. $x 410. $x 240. $x 350. $x 750 150 $a lenograstim $2 czmesh 450 $w i $a Euprotin $i UF 450 $w i $a Granocyte $i UF 450 $w i $a Lenograstim, Component 1 $i UF 450 $w i $a Lenograstim, Component 2 $i UF 450 $w i $a Neutrogin $i UF 550 $w g $a faktor stimulující kolonie granulocytů $7 upol_us_auth*d016179 550 $w i $a adjuvancia imunologická $i PA $7 upol_us_auth*d000276 550 $w i $a hematologické látky $i PA $7 upol_us_auth*d006401 680 $i A recombinant granulocyte colony-stimulating factor that is used to treat or prevent NEUTROPENIA in patients receiving myelosuppressive cancer chemotherapy, for the preparation and collection of blood progenitor cells in PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; and in the treatment of severe congenital neutropenia. Component 1 and Component 2 differ by absence or presence of Neu5Ac in 2-6 linkage to GalNAc side chain. 688 $a 2019 (1993) 750 -2
$a Lenograstim $2 czmesh 980 $x M 982 $a 1
Number of the records: 1